These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9862301)

  • 1. Neuropathic pain in Charcot-Marie-Tooth disease.
    Carter GT; Jensen MP; Galer BS; Kraft GH; Crabtree LD; Beardsley RM; Abresch RT; Bird TD
    Arch Phys Med Rehabil; 1998 Dec; 79(12):1560-4. PubMed ID: 9862301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale.
    Argoff CE; Galer BS; Jensen MP; Oleka N; Gammaitoni AR
    Curr Med Res Opin; 2004; 20 Suppl 2():S21-8. PubMed ID: 15563743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of neuropathic pain in patients with Charcot-Marie-Tooth 1 A: a laser-evoked potential study.
    Pazzaglia C; Vollono C; Ferraro D; Virdis D; Lupi V; Le Pera D; Tonali P; Padua L; Valeriani M
    Pain; 2010 May; 149(2):379-385. PubMed ID: 20334975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale.
    Galer BS; Jensen MP; Ma T; Davies PS; Rowbotham MC
    Clin J Pain; 2002; 18(5):297-301. PubMed ID: 12218500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale.
    Galer BS; Jensen MP
    Neurology; 1997 Feb; 48(2):332-8. PubMed ID: 9040716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pain assessment in Charcot-Marie-Tooth (CMT) disease.
    Ribiere C; Bernardin M; Sacconi S; Delmont E; Fournier-Mehouas M; Rauscent H; Benchortane M; Staccini P; Lantéri-Minet M; Desnuelle C
    Ann Phys Rehabil Med; 2012 Apr; 55(3):160-73. PubMed ID: 22475878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropathic pain model of peripheral neuropathies mediated by mutations of glycyl-tRNA synthetase.
    Lee SJ; Seo AJ; Park BS; Jo HW; Huh Y
    J Korean Med Sci; 2014 Aug; 29(8):1138-44. PubMed ID: 25120326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic epidemiology of Charcot-Marie-Tooth disease.
    Braathen GJ
    Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials.
    Sang CN; Booher S; Gilron I; Parada S; Max MB
    Anesthesiology; 2002 May; 96(5):1053-61. PubMed ID: 11981142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of S-LANSS, a tool for screening neuropathic pain, for predicting postherpetic neuralgia in patients after acute herpes zoster events: a single-center, 12-month, prospective cohort study.
    Cho SI; Lee CH; Park GH; Park CW; Kim HO
    J Pain; 2014 Feb; 15(2):149-56. PubMed ID: 24342706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex regional pain syndrome-like symptoms during herpes zoster.
    Berry JD; Rowbotham MC; Petersen KL
    Pain; 2004 Jul; 110(1-2):e1-12. PubMed ID: 15275746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for postherpetic neuralgia in patients with herpes zoster.
    Jung BF; Johnson RW; Griffin DR; Dworkin RH
    Neurology; 2004 May; 62(9):1545-51. PubMed ID: 15136679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of common causes of neuropathic pain in Korea: population-based observational study.
    Bang S; Kim YS; Lee S; Park U; Kim TK; Choi Y
    J Int Med Res; 2020 Jul; 48(7):300060519888102. PubMed ID: 31775560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathic pain in patients with Charcot-Marie-Tooth type 1A.
    Bjelica B; Peric S; Basta I; Bozovic I; Kacar A; Marjanovic A; Ivanovic V; Brankovic M; Jankovic M; Novakovic I; Rakocevic Stojanovic V
    Neurol Sci; 2020 Mar; 41(3):625-630. PubMed ID: 31729581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial.
    Rowbotham M; Harden N; Stacey B; Bernstein P; Magnus-Miller L
    JAMA; 1998 Dec; 280(21):1837-42. PubMed ID: 9846778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogenous patterns of sensory dysfunction in postherpetic neuralgia suggest multiple pathophysiologic mechanisms.
    Pappagallo M; Oaklander AL; Quatrano-Piacentini AL; Clark MR; Raja SN
    Anesthesiology; 2000 Mar; 92(3):691-8. PubMed ID: 10719948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral trigeminal neuralgia and charcot-marie-tooth disease: diagnosis and successful microsurgical treatment of bilateral neurovascular compression.
    Tekkok IH; Sumer M
    Zentralbl Neurochir; 2008 Aug; 69(3):148-51. PubMed ID: 18666057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pain and small fiber function in Charcot-Marie-Tooth disease type 1A.
    Laurà M; Hutton EJ; Blake J; Lunn MP; Fox Z; Pareyson D; Solari A; Radice D; Koltzenburg M; Reilly MM
    Muscle Nerve; 2014 Sep; 50(3):366-71. PubMed ID: 24395492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Validation of the Italian version of the "Neuropathic Pain Scale" and its clinical applications].
    Negri E; Bettaglio R; Demartini L; Allegri M; Barbieri M; Miotti D; Paulin L; Buonocore M; Bonezzi C
    Minerva Anestesiol; 2002 Mar; 68(3):95-104. PubMed ID: 11981518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient Reported Outcomes Using Medical Cannabis for Managing Pain in Charcot-Marie-Tooth Disease.
    Canals PC; Aguilar AG; Carter GT; Shields CM; Westerkamp A; D'Elia M; Aldrich J; Moore RN; Moore AT; Piper BJ
    Am J Hosp Palliat Care; 2023 Nov; 40(11):1163-1167. PubMed ID: 36793224
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.